Table 3 Treatment regimens of study patients

Quinine (iv) + Clindamycin (po)

9

0/4

Quinine (iv) + Doxycycline (po)

16

0/3

Quinine (iv) monotherapy

1

0/1

Quinine (iv) + Clindamycin (po) + Artesunate (ir)

1

1/1

Quinine (iv) + Doxycycline (po) + Artesunate (ir)

3

1/2

Quinine (iv) + Artesunate (ir)

1

0/1

Artesunate (iv) with subsequent Atovaquone/Proguanil (po)

4

2/3

Artesunate (iv) with subsequent Mefloquine (po)

1

1/1